Journal · Updated 2026-08-11
Certificates of Analysis for Compounded GLP-1s: What a Real COA Shows, and How to Read One
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
A certificate of analysis is the lab report card for a specific batch: it should establish identity (the peptide is what the label claims), potency (measured strength against the labeled concentration, with an acceptable-range specification), sterility (no microbial growth), and endotoxin results (bacterial-residue limits for injectables) — tied to a lot number that matches the vial in your hand, dated, and ideally issued or confirmed by an independent third-party laboratory rather than solely in-house. It's the single document that converts a pharmacy's quality claims into checkable data, which is why "Can you provide the certificate of analysis for my lot?" sits in our vetting checklist — and why the response is itself a result: a routine yes is the norm among quality operations, and a refusal, a dodge, or a COA that never matches your lot has answered a different question.
Reading one like it matters
The checklist, in order: lot match — the COA's lot number equals your vial's label; a generic "representative" certificate describes someone else's batch. Identity method — the document should name its analytical technique for confirming the molecule; the presence of a named method matters more to a lay reader than parsing it. Potency with a specification — a measured value and the acceptable range (commonly a band around 100% of label); a number without a spec range is a fact without a verdict, and a result outside the stated range is a call to the pharmacy before injection. Sterility and endotoxin — pass/within-limit results for both, non-negotiable for an injectable. Issuer and date — an identifiable laboratory, a test date that makes sense against the BUD from the shelf-life guide. What a COA is not: a substitute for the pharmacy-level checks (state license in your state, FDA compounding records — the checklist's other lanes), an FDA approval (nothing compounded has one), or a guarantee about the vial's handling after testing. It's one strong link in a chain — and in a market where our error-report file documents concentration mistakes, it's the link that checks the number your syringe math depends on.
Questions people ask
What should a GLP-1 certificate of analysis include?
Identity confirmation (named analytical method), measured potency with an acceptable-range specification, sterility results, endotoxin results, a lot number matching your vial, a test date, and an identifiable — ideally independent third-party — laboratory. A 'representative' COA that doesn't match your lot describes someone else's batch.
How do I get a COA from a telehealth GLP-1 program?
Ask in writing, with your lot number, once the pharmacy is named: 'Please provide the certificate of analysis for lot X.' Quality operations treat this as routine. Refusal, indefinite delay, or a lot mismatch is itself the answer — our vetting checklist scores the response either way.
Does a good COA mean the compounded product is FDA-approved?
No — nothing compounded is FDA-approved; a COA is batch-level quality evidence, not agency review. It's one strong link alongside the pharmacy checks (state licensure, FDA compounding records) — necessary, and not sufficient alone.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.